论文部分内容阅读
目的:探讨超敏C反应蛋白用于诊断小儿肺炎的临床价值。方法:随机选择2015年8月~2016年8月收治的90例小儿肺炎患者为观察组,并根据疾病类型分为三个亚组,分别为病毒性肺炎组(A组,30例)、细菌性肺炎组(B组,30例)、支原体性肺炎组(C组,30例)。并选择同期30例健康体检儿为对照组,比较两组超敏C反应蛋白水平。结果:B、C两组患儿超敏C反应蛋白水平显著高于对照组,差异有统计学意义(P<0.05),但A组患儿与对照组比较差异无统计学意义(P>0.05);B组阳性检出率为100%,A组为30.0%,C组为90.0%。B、C两组阳性检出率显著高于A组(P<0.05),但B、C两组比较差异无统计学意义(P>0.05)。结论:超敏C反应蛋白可有效诊断小儿肺炎,值得推广应用。
Objective: To investigate the clinical value of hypersensitive C-reactive protein in diagnosing childhood pneumonia. Methods: A total of 90 children with pneumonia admitted from August 2015 to August 2016 were randomly divided into three subgroups: viral pneumonia group (group A, n = 30), bacterial Pneumonia group (group B, 30 cases), mycoplasma pneumonia group (group C, 30 cases). 30 healthy subjects were selected as the control group in the same period, and the levels of hypersensitive C-reactive protein were compared between the two groups. Results: The levels of Hs-CRP in B and C groups were significantly higher than those in control group (P <0.05), but there was no significant difference between A group and control group (P> 0.05 ); The positive detection rate of group B was 100%, group A was 30.0% and group C was 90.0%. The positive rate of B and C in both groups was significantly higher than that in group A (P <0.05), but there was no significant difference between B and C groups (P> 0.05). Conclusion: Hypersensitive C-reactive protein can diagnose pediatric pneumonia effectively and is worth popularizing.